Protalix BioTherapeutics
PLX
#8909
Rank
HK$1.09 B
Marketcap
HK$13.62
Share price
1.74%
Change (1 day)
7.37%
Change (1 year)

Protalix BioTherapeutics (PLX) - Net assets

Net assets on the balance sheet as of June 2025 : HK$0.38 Billion

According to Protalix BioTherapeutics 's latest financial reports the company has HK$0.38 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Protalix BioTherapeutics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$HK$0.33 B27.96%
2023-12-31$HK$0.26 B-415.37%
2022-12-31$-HK$83.14 Million76.63%
2021-12-31$-HK$47.07 Million-77.54%
2020-12-31$-HK$0.21 Billion-61.73%
2019-12-31$-HK$0.55 Billion32.25%
2018-12-31$-HK$0.42 Billion79.93%
2017-12-31$-HK$0.24 Billion198.07%
2016-12-31$-HK$77.22 Million-191.62%
2015-12-31$HK$84.27 M-119.54%
2014-12-31$-HK$0.44 Billion106.4%
2013-12-31$-HK$0.21 Billion703.01%
2012-12-31$-HK$26.03 Million-87.15%
2011-12-31$-HK$0.21 Billion129.85%
2010-12-31$-HK$88.12 Million-171.55%
2009-12-31$HK$0.12 B-64.06%
2008-12-31$HK$0.34 B-30.99%
2007-12-31$HK$0.49 B162.91%
2006-12-31$HK$0.18 B299.67%
2005-12-31$HK$47.25 M1128.48%
2004-12-31$HK$3.84 M-24.28%
2003-12-31$HK$5.08 M-18.17%
2002-12-31$HK$6.2 M-15.82%
2001-12-31$HK$7.37 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Amicus Therapeutics
FOLD
HK$1.79 B 361.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$23.38 B 5,918.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$724.72 B 186,453.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$56.47 B 14,436.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel